{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:14:14Z","timestamp":1770362054538,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"\"Medical and Industrial Cross Research Fund\" of Shanghai Jiao Tong University \"Jiao Tong University Star\" Program","award":["YG2023QNB28"],"award-info":[{"award-number":["YG2023QNB28"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10735-025-10490-8","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T08:03:46Z","timestamp":1759219426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of NR4A3 increases sensitivity to niraparib in ovarian cancer cells resistant to this drug"],"prefix":"10.1007","volume":"56","author":[{"given":"Jianwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"10490_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"Allemani, C, Matsuda, T, Di Carlo, V, Harewood, R, Matz, M, Niksic, M, Bonaventure, A, Valkov, M, Johnson, CJ, Esteve, J, Ogunbiyi, OJ, Azevedo, ESG, Chen, WQ, Eser, S, Engholm, G, Stiller, CA, Monnereau, A, Woods, RR, Visser, O, Lim, GH, Aitken, J, Weir, HK, Coleman, MP, Group, CW","year":"2018","unstructured":"Allemani, C, Matsuda, T, Di Carlo, V, Harewood, R, Matz, M, Niksic, M, Bonaventure, A, Valkov, M, Johnson, CJ, Esteve, J, Ogunbiyi, OJ, Azevedo, ESG, Chen, WQ, Eser, S, Engholm, G, Stiller, CA, Monnereau, A, Woods, RR, Visser, O, Lim, GH, Aitken, J, Weir, HK, Coleman, MP, Group, CW (2018) Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023\u20131075. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3","journal-title":"Lancet"},{"key":"10490_CR2","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1002\/cam4.1530","volume":"7","author":"MR Alves","year":"2018","unstructured":"Alves MR, e melo NC, Barros-Filho MC, de Amaral NS, Silva FI, Baiocchi Neto G, Soares FA, de Brot AL, Rocha RM (2018) Downregulation of AGR2, p21, and cyclin D and alterations in p53 function were associated with tumor progression and chemotherapy resistance in epithelial ovarian carcinoma. Cancer Med 7:3188\u20133199. https:\/\/doi.org\/10.1002\/cam4.1530","journal-title":"Cancer Med"},{"key":"10490_CR3","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1038\/s41467-018-07855-x","volume":"9","author":"JR Becker","year":"2018","unstructured":"Becker JR, Cuella-Martin R, Barazas M, Liu R, Oliveira C, Oliver AW, Bilham K, Holt AB, Blackford AN, Heierhorst J, Jonkers J, Rottenberg S, Chapman JR (2018) The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity. Nat Commun 9:5406. https:\/\/doi.org\/10.1038\/s41467-018-07855-x","journal-title":"Nat Commun"},{"key":"10490_CR4","doi-asserted-by":"publisher","first-page":"960327122112985","DOI":"10.1177\/09603271221129854","volume":"41","author":"P Che","year":"2022","unstructured":"Che P, Jiang S, Zhang W, Zhu H, Hu D, Wang D (2022) A comprehensive gene expression profile analysis of prostate cancer cells resistant to paclitaxel and the potent target to reverse resistance. Hum Exp Toxicol 41:9603271221129854. https:\/\/doi.org\/10.1177\/09603271221129854","journal-title":"Hum Exp Toxicol"},{"key":"10490_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"key":"10490_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092114","author":"D Doheny","year":"2020","unstructured":"Doheny D, Manore SG, Wong GL, Lo HW (2020) Hedgehog signaling and truncated GLI1 in cancer. Cells. https:\/\/doi.org\/10.3390\/cells9092114","journal-title":"Cells"},{"key":"10490_CR7","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1111\/bph.13091","volume":"172","author":"XJ Feng","year":"2015","unstructured":"Feng XJ, Gao H, Gao S, Li Z, Li H, Lu J, Wang JJ, Huang XY, Liu M, Zou J, Ye JT, Liu PQ (2015) The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1. Br J Pharmacol 172:2852\u20132863. https:\/\/doi.org\/10.1111\/bph.13091","journal-title":"Br J Pharmacol"},{"key":"10490_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s42003-024-06142-4","volume":"7","author":"L Feng","year":"2024","unstructured":"Feng L, Yan W, Tang X, Wu H, Pan Y, Lu D, Ling-Hu Q, Liu Y, Liu Y, Song X, Ali M, Fang L, Guo H, Li B (2024) Multiple factors and features dictate the selective production of ct-siRNA in Arabidopsis. Commun Biol 7:474. https:\/\/doi.org\/10.1038\/s42003-024-06142-4","journal-title":"Commun Biol"},{"key":"10490_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-021-02060-z","volume":"40","author":"D Fessart","year":"2021","unstructured":"Fessart D, Robert J, Hartog C, Chevet E, Delom F, Babin G (2021) The anterior GRadient (AGR) family proteins in epithelial ovarian cancer. J Exp Clin Cancer Res 40:271. https:\/\/doi.org\/10.1186\/s13046-021-02060-z","journal-title":"J Exp Clin Cancer Res"},{"key":"10490_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s13577-022-00748-8","volume":"35","author":"L Fu","year":"2022","unstructured":"Fu L, Zhang D, Yi N, Cao Y, Wei Y, Wang W, Li L (2022) Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression. Hum Cell 35:1560\u20131576. https:\/\/doi.org\/10.1007\/s13577-022-00748-8","journal-title":"Hum Cell"},{"key":"10490_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fnagi.2020.00165","volume":"12","author":"R Gao","year":"2020","unstructured":"Gao R, Chen C, Zhao Q, Li M, Wang Q, Zhou L, Chen E, Chen H, Zhang Y, Cai X, Liu C, Cheng X, Zhang S, Mao X, Qiu Y, Gan L, Yu H, Liu J, Zhu T (2020) Identification of the potential key circular RNAs in elderly patients with postoperative cognitive dysfunction. Front Aging Neurosci 12:165. https:\/\/doi.org\/10.3389\/fnagi.2020.00165","journal-title":"Front Aging Neurosci"},{"key":"10490_CR12","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","volume":"381","author":"A Gonzalez-Martin","year":"2019","unstructured":"Gonzalez-Martin A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O\u2019Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Perez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ, Investigators, PE-OG- (2019) Niraparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med 381:2391\u20132402. https:\/\/doi.org\/10.1056\/NEJMoa1910962","journal-title":"N Engl J Med"},{"key":"10490_CR13","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.2147\/OTT.S217975","volume":"12","author":"H Guan","year":"2019","unstructured":"Guan H, Li J, Sun R, Liu W, Feng M, Ma H, Li C (2019) Expression of BMP7 In ovarian cancer and biological effect of BMP7 knockdown on ovarian cancer cells. Onco Targets Ther 12:7897\u20137909. https:\/\/doi.org\/10.2147\/OTT.S217975","journal-title":"Onco Targets Ther"},{"key":"10490_CR14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.5306\/wjco.v12.i7.544","volume":"12","author":"E Imyanitov","year":"2021","unstructured":"Imyanitov E, Sokolenko A (2021) Mechanisms of acquired resistance of BRCA1\/2-driven tumors to platinum compounds and PARP inhibitors. World J Clin Oncol 12:544\u2013556. https:\/\/doi.org\/10.5306\/wjco.v12.i7.544","journal-title":"World J Clin Oncol"},{"key":"10490_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030758","author":"KS Jeng","year":"2020","unstructured":"Jeng KS, Chang CF, Lin SS (2020) Sonic hedgehog signaling in organogenesis, tumors, and tumor microenvironments. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21030758","journal-title":"Int J Mol Sci"},{"key":"10490_CR16","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1111\/jcmm.14133","volume":"23","author":"X Jiang","year":"2019","unstructured":"Jiang X, Li X, Li W, Bai H, Zhang Z (2019) PARP inhibitors in ovarian cancer: sensitivity prediction and resistance mechanisms. J Cell Mol Med 23:2303\u20132313. https:\/\/doi.org\/10.1111\/jcmm.14133","journal-title":"J Cell Mol Med"},{"key":"10490_CR17","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3892\/or.2019.7275","volume":"42","author":"E Katsuta","year":"2019","unstructured":"Katsuta E, Maawy AA, Yan L, Takabe K (2019) High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor-positive breast cancer. Oncol Rep 42:1413\u20131421. https:\/\/doi.org\/10.3892\/or.2019.7275","journal-title":"Oncol Rep"},{"key":"10490_CR18","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1038\/s41467-020-17127-2","volume":"11","author":"H Kim","year":"2020","unstructured":"Kim H, Xu H, George E, Hallberg D, Kumar S, Jagannathan V, Medvedev S, Kinose Y, Devins K, Verma P, Ly K, Wang Y, Greenberg RA, Schwartz L, Johnson N, Scharpf RB, Mills GB, Zhang R, Velculescu VE, Brown EJ, Simpkins F (2020) Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models. Nat Commun 11:3726. https:\/\/doi.org\/10.1038\/s41467-020-17127-2","journal-title":"Nat Commun"},{"key":"10490_CR19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11523-021-00841-2","volume":"16","author":"A Lee","year":"2021","unstructured":"Lee A (2021) Niraparib: a review in first-line maintenance therapy in advanced ovarian cancer. Target Oncol 16:839\u2013845. https:\/\/doi.org\/10.1007\/s11523-021-00841-2","journal-title":"Target Oncol"},{"key":"10490_CR20","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.biocel.2013.06.020","volume":"45","author":"W Li","year":"2013","unstructured":"Li W, Li X, Wang W, Yi M, Zhou Y, Zheng P, Xiong W, Yang J, Peng S, McCarthy JB, Xiang B, Li G (2013) Tumor suppressor gene Oxidored-nitro domain-containing protein 1 regulates nasopharyngeal cancer cell autophagy, metabolism, and apoptosis in vitro. Int J Biochem Cell Biol 45:2016\u20132026. https:\/\/doi.org\/10.1016\/j.biocel.2013.06.020","journal-title":"Int J Biochem Cell Biol"},{"key":"10490_CR21","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","volume":"375","author":"MR Mirza","year":"2016","unstructured":"Mirza MR, Monk BJ, Herrstedt J, Oza AM, Mahner S, Redondo A, Fabbro M, Ledermann JA, Lorusso D, Vergote I, Ben-Baruch NE, Marth C, Madry R, Christensen RD, Berek JS, Dorum A, Tinker AV, du Bois A, Gonzalez-Martin A, Follana P, Benigno B, Rosenberg P, Gilbert L, Rimel BJ, Buscema J, Balser JP, Agarwal S, Matulonis UA, Investigators E-ON (2016) Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N Engl J Med 375:2154\u20132164. https:\/\/doi.org\/10.1056\/NEJMoa1611310","journal-title":"N Engl J Med"},{"key":"10490_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/1574892813666180305165256","volume":"13","author":"G Mittica","year":"2018","unstructured":"Mittica G, Ghisoni E, Giannone G, Genta S, Aglietta M, Sapino A, Valabrega G (2018) PARP Inhibitors in ovarian cancer. Recent Pat Anticancer Drug Discov 13:392\u2013410. https:\/\/doi.org\/10.2174\/1574892813666180305165256","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10490_CR23","doi-asserted-by":"publisher","first-page":"e05000","DOI":"10.1016\/j.heliyon.2020.e05000","volume":"6","author":"NA Moidu","year":"2020","unstructured":"Moidu NA, Rahman NS, Syafruddin SE, Low TY, Mohtar MA (2020) Secretion of pro-oncogenic AGR2 protein in cancer. Heliyon 6:e05000. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05000","journal-title":"Heliyon"},{"key":"10490_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/jcb.21876","volume":"105","author":"N Ohkura","year":"2008","unstructured":"Ohkura N, Nagamura Y, Tsukada T (2008) Differential transactivation by orphan nuclear receptor NOR1 and its fusion gene product EWS\/NOR1: possible involvement of poly(ADP-ribose) polymerase I, PARP-1. J Cell Biochem 105:785\u2013800. https:\/\/doi.org\/10.1002\/jcb.21876","journal-title":"J Cell Biochem"},{"key":"10490_CR25","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1002\/cam4.4018","volume":"10","author":"Y Pan","year":"2021","unstructured":"Pan Y, Zhou J, Zhang W, Yan L, Lu M, Dai Y, Zhou H, Zhang S, Yang J (2021) The Sonic Hedgehog signaling pathway regulates autophagy and migration in ovarian cancer. Cancer Med 10:4510\u20134521. https:\/\/doi.org\/10.1002\/cam4.4018","journal-title":"Cancer Med"},{"key":"10490_CR26","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S1470-2045(17)30469-2","volume":"18","author":"E Pujade-Lauraine","year":"2017","unstructured":"Pujade-Lauraine E, Ledermann JA, Selle F, Gebski V, Penson RT, Oza AM, Korach J, Huzarski T, Poveda A, Pignata S, Friedlander M, Colombo N, Harter P, Fujiwara K, Ray-Coquard I, Banerjee S, Liu J, Lowe ES, Bloomfield R, Pautier P, investigators, SOE-O, (2017) Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol 18:1274\u20131284. https:\/\/doi.org\/10.1016\/S1470-2045(17)30469-2","journal-title":"Lancet Oncol"},{"key":"10490_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1158\/1541-7786.MCR-20-0707","volume":"19","author":"S Safe","year":"2021","unstructured":"Safe S, Karki K (2021) The paradoxical roles of orphan nuclear receptor 4A (NR4A) in cancer. Mol Cancer Res 19:180\u2013191. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0707","journal-title":"Mol Cancer Res"},{"key":"10490_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrendo.2016.12","volume":"12","author":"VS Salazar","year":"2016","unstructured":"Salazar VS, Gamer LW, Rosen V (2016) BMP signalling in skeletal development, disease and repair. Nat Rev Endocrinol 12:203\u2013221. https:\/\/doi.org\/10.1038\/nrendo.2016.12","journal-title":"Nat Rev Endocrinol"},{"key":"10490_CR29","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3892\/ijo.2018.4469","volume":"53","author":"W Shen","year":"2018","unstructured":"Shen W, Pang H, Xin B, Duan L, Liu L, Zhang H (2018) Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis. Int J Oncol 53:1354\u20131362. https:\/\/doi.org\/10.3892\/ijo.2018.4469","journal-title":"Int J Oncol"},{"key":"10490_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"10490_CR31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11864-022-00938-4","volume":"23","author":"M Smith","year":"2022","unstructured":"Smith M, Pothuri B (2022) Appropriate Selection of PARP Inhibitors in Ovarian Cancer. Curr Treat Options Oncol 23:887\u2013903. https:\/\/doi.org\/10.1007\/s11864-022-00938-4","journal-title":"Curr Treat Options Oncol"},{"key":"10490_CR32","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/abbs\/gmaa085","volume":"52","author":"L Song","year":"2020","unstructured":"Song L, Cui Z, Guo X (2020) Comprehensive analysis of circular RNA expression profiles in cisplatin-resistant non-small cell lung cancer cell lines. Acta Biochim Biophys Sin (Shanghai) 52:944\u2013953. https:\/\/doi.org\/10.1093\/abbs\/gmaa085","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10490_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3969\/j.issn.1672-7347.2014.08.001","volume":"39","author":"Y Tan","year":"2014","unstructured":"Tan Y, Li W, Yi M, Wang W, Zheng P, Zhang H, Xiang B, Li G (2014) Effect of NOR1 gene knockdown on the biological behavior of HeLa cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban 39:757\u2013763. https:\/\/doi.org\/10.3969\/j.issn.1672-7347.2014.08.001","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10490_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1757-2215-7-23","volume":"7","author":"MT Wiiger","year":"2014","unstructured":"Wiiger MT, Bideli H, Fodstad O, Flatmark K, Andersson Y (2014) The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells. J Ovarian Res 7:23. https:\/\/doi.org\/10.1186\/1757-2215-7-23","journal-title":"J Ovarian Res"},{"key":"10490_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2007.12.010","volume":"29","author":"L Wu","year":"2008","unstructured":"Wu L, Belasco JG (2008) Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell 29:1\u20137. https:\/\/doi.org\/10.1016\/j.molcel.2007.12.010","journal-title":"Mol Cell"},{"key":"10490_CR36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 135:584\u2013590. https:\/\/doi.org\/10.1097\/CM9.0000000000002108","journal-title":"Chin Med J (Engl)"},{"key":"10490_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1871520619666190307120441","volume":"19","author":"YL Xu","year":"2019","unstructured":"Xu YL, Jiang XM, Zhang LL, Chen X, Huang ZJ, Lu JJ (2019) Establishment and Characterization of Pemetrexed-resistant NCI-H460\/PMT Cells. Anticancer Agents Med Chem 19:731\u2013739. https:\/\/doi.org\/10.2174\/1871520619666190307120441","journal-title":"Anticancer Agents Med Chem"},{"key":"10490_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/bmm-2023-0178","volume":"17","author":"T Yan","year":"2023","unstructured":"Yan T, Wang H, Ma X, Cao J, Tong Y, Guo L, Lu R (2023) Clinical value of serum and tissue AGR2 for diagnosis and prognosis in epithelial ovarian cancer. Biomark Med 17:325\u2013336. https:\/\/doi.org\/10.2217\/bmm-2023-0178","journal-title":"Biomark Med"},{"key":"10490_CR39","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.3892\/ol.2018.7949","volume":"15","author":"W Zhang","year":"2018","unstructured":"Zhang W, Yu F, Wang Y, Zhang Y, Meng L, Chi Y (2018) Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway. Oncol Lett 15:5155\u20135160. https:\/\/doi.org\/10.3892\/ol.2018.7949","journal-title":"Oncol Lett"},{"key":"10490_CR40","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.3892\/or.2020.7798","volume":"44","author":"H Zhang","year":"2020","unstructured":"Zhang H, Hu L, Cheng M, Wang Q, Hu X, Chen Q (2020) The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer. Oncol Rep 44:2610\u20132620. https:\/\/doi.org\/10.3892\/or.2020.7798","journal-title":"Oncol Rep"},{"key":"10490_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3892\/or.2020.7668","volume":"44","author":"K Zhang","year":"2020","unstructured":"Zhang K, Wang W, Chen L, Liu Y, Hu J, Guo F, Tian W, Wang Y, Xue F (2020) Cross-validation of genes potentially associated with neoadjuvant chemotherapy and platinum-based chemoresistance in epithelial ovarian carcinoma. Oncol Rep 44:909\u2013926. https:\/\/doi.org\/10.3892\/or.2020.7668","journal-title":"Oncol Rep"}],"updated-by":[{"DOI":"10.1007\/s10735-026-10725-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000}}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10490-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10490-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10490-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:53:46Z","timestamp":1770256426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10490-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10490"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10490-8","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10735-026-10725-2","URL":"https:\/\/doi.org\/10.1007\/s10735-026-10725-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"331"}}